Consolidated Statement Of Comprehensive Income

JCR Pharmaceuticals Co.,Ltd. - Filing #7295903

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-680,000,000 JPY
5,260,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
1,863,000,000 JPY
73,000,000 JPY
Deferred gains or losses on hedges
8,000,000 JPY
JPY
Foreign currency translation adjustment
208,000,000 JPY
103,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-12,000,000 JPY
0 JPY
Share of other comprehensive income of entities accounted for using equity method
401,000,000 JPY
441,000,000 JPY
Other comprehensive income
2,469,000,000 JPY
617,000,000 JPY
Comprehensive income
1,788,000,000 JPY
5,877,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
1,740,000,000 JPY
5,857,000,000 JPY
Comprehensive income attributable to non-controlling interests
48,000,000 JPY
20,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.